SciSparc Ltd Ordinary Shares SPRC 深 滬
等待開盤 07-24 09:30:00 美东时间
8.0034
-0.187
-2.28%
華盛通- 最 高8.48
- 今 開8.20
- 成交量 3.71万股
- 最 低 7.78
- 昨 收 8.19
- 總市值 8984.46万
- 52周最高 37.59
- 市盈率 靜 --
- 換手率 0.33%
- 52周最低 4.137
- 委 比 33.33%
- 總股本 1122.58万
- 歷史最高 3865.68
- 量 比 0.71
- 振 幅 8.55%
- 歷史最低 4.137
- 每 手 1
- 風險率 2.26%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多SciSparc Ltd. Executes Reverse Share Split Amid Financial Challenges
SciSparc Ltd. ( ($SPRC) ) has provided an announcement. On July 3, 2025, SciSpa...
07-23 04:27
SciSparc Ltd. Regains Nasdaq Compliance
SciSparc Ltd. ( ($SPRC) ) has provided an update. On July 22, 2025, SciSparc Lt...
07-22 20:57
SciSparc regains compliance with Nasdaq’s listing rule
SciSparc (NASDAQ:SPRC) has regained compliance with Nasdaq’s Listing Rule 5550(a)(2), which requires the company’s ordinary shares to maintain a minimum bid price of $1.00 per share. The Nasdaq staff ...
07-22 19:39
SciSparc Ltd. Regains Compliance with Nasdaq Minimum Bid Price Notification
SciSparc Ltd. (Nasdaq: SPRC), a clinical-stage pharmaceutical company focusing on cannabinoid-based therapies for central nervous system disorders, has regained compliance with Nasdaq Listing Rule 5550(a)(2) after its shares maintained a minimum bid price of $1.00 for 10 consecutive business days. The company develops treatments for Tourette Syndrome, Alzheimer's disease, autism, and epilepsy using THC and/or CBD. It also operates a hemp seed oil...
07-22 11:32
SciSparc to implement 1-for-21 reverse share split; shares down
SciSparc (NASDAQ:SPRC) will enact a 1-for-21 reverse share split of its ordinary shares. The reverse split will take effect at market open on July 3, 2025. SPRC shares fall 8.6% post-market on Tuesday...
06-25 05:16
SciSparc Announces 1-for-21 Reverse Share Split
SciSparc Ltd. (Nasdaq: SPRC) announced a 1-for-21 reverse share split effective July 3. Outstanding shares will decrease to approximately 534,600 from 11,225,751. Fractional shares will be rounded up, and ownership percentages remain unchanged. Trading resumes under "SPRC" with a new CUSIP number. No action needed for brokerage-held shares. SciSparc focuses on cannabinoid therapies for CNS disorders, including treatments for Tourette's, Alzheimer...
06-24 21:03
SciSparc Ltd. Advances Merger with AutoMax Motors
An update from SciSparc Ltd. ( ($SPRC) ) is now available. SciSparc Ltd. has an...
06-10 04:28
SciSparc announces publication of Japanese patent application
SciSparc (NASDAQ:SPRC) has announced the publication of a Japanese divisional patent. The patent application introduces a novel pharmaceutical combination of paracetamol and palmitoylethanolamide that...
05-27 20:46
Psychedelic stocks rise as FDA chief’s comments seen favorable to industry
Companies focused on psychedelic medicines traded higher for the second straight session on Tuesday after FDA Commissioner Marty Makary said evaluating the potential of psilocybin, MDMA, and other psy...
05-20 22:46
SciSparc Announced That Its Collaboration With Clearmind Medicine Has Led To The Publication Of A European Patent Application By The European Patent Office
The patent application relates to a combination treatment using Clearmind's 5-methoxy-2-aminoindane ("MEAI") and SciSparc's Palmitoylethanolamide for the treatment of cocaine addiction.
05-12 19:36
